New Heart Device Treats Calcium Deposits

Tuesday, 22 Oct 2013 12:08 PM

 

  Comment  |
   Contact  |
  Print   |
    A   A  
  Copy Shortlink

Cardiovascular Systems Inc said it received the U.S. health regulator's approval to market its heart device to treat severe accumulation of calcium in coronary arteries, sending its shares up as much as 23 percent.
The device, Diamondback 360 Coronary Orbital Atherectomy System, will be launched immediately, the company said in a statement on Tuesday.
Plaque buildup, including calcium deposits, in arteries reduces blood supply to the heart, leading to coronary artery disease.
The company estimated the U.S. market opportunity for the device to exceed $1.5 billion annually.
CSI shares touched a near six-year high of $27.90 in early trade, but gave up some of their gains to be up at $26.31 on the Nasdaq.

© 2014 Thomson/Reuters. All rights reserved.

  Comment  |
   Contact  |
  Print   |
  Copy Shortlink
Around the Web
Comments
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Find Your Condition
You May Also Like
Around the Web
Most Commented

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAXHEALTH.COM
© Newsmax Media, Inc.
All Rights Reserved
> >